Docking and molecular dynamics studies of the binding between Peloruside A and tubulin

References

• Singh P, Rathinasamy K, Mohan R, Panda D. Microtubule assembly dynamics: an attractive target for anticancer drugs. Iubmb Life 2008;60:368–75
   PubMed Web of Science ®Google Scholar
• Jordan MA, Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 1998;10:123–30
   PubMed Web of Science ®Google Scholar
• Rowinsky EK. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 1997;48:353–74
   PubMed Web of Science ®Google Scholar
• Orr GA, Verdier-Pinard P, McDaid H, Horwitz SB. Mechanisms of Taxol resistance related to microtubules. Oncogene 2003;22:7280–95
   PubMed Web of Science ®Google Scholar
• West LM, Northcote PT, Battershill CN, Peloruside A. A potent cytotoxic macrolide isolated from the New Zealand marine sponge Mycale sp. J Org Chem 2000;65:445–9
   PubMed Web of Science ®Google Scholar
• Miller JH, Rouwé B, Gaitanos TN, et al. Peloruside A enhances apoptosis in H-ras-transformed cells and is cytotoxic to proliferating T cells. Apoptosis 2004;9:785–96
   PubMed Web of Science ®Google Scholar
• Hood KA, West LM, Rouwe B, et al. Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule-stabilizing activity. Cancer Res 2002;62:3356–60
   PubMed Web of Science ®Google Scholar
• Gaitanos TN, Buey RM, Díaz JF, et al. Peloruside A does not bind to the taxoid site on β-tubulin and retains its activity in multidrug resistant cell lines. Cancer Res 2004;64:5063–7
   PubMed Web of Science ®Google Scholar
• Crume KP, O’Sullivan D, Miller JH, et al. Delaying the onset of experimental autoimmune encephalomyelitis with the microtubule-stabilizing compounds, paclitaxel and peloruside A. J Leukocyte Biol 2009;86:949–58
   PubMed Web of Science ®Google Scholar
• Hamel E, Day BW, Miller JH, et al. Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly. Mol Pharmacol 2006;70:1555–64
   PubMed Web of Science ®Google Scholar
• Pineda O, Farràs J, Maccari L, et al. Computational comparison of microtubule-stabilizing agents laulimalide and peloruside with taxol and colchicine. Bioorg Med Chem Lett 2004;14:4825–9
   PubMed Web of Science ®Google Scholar
• Jiménez-Barbero J, Canales A, Northcote PT, et al. NMR determination of the bioactive conformation of peloruside A bound to microtubules. J Am Chem Soc 2006;128:8757–65
   PubMed Web of Science ®Google Scholar
• Huzil JT, Chik JK, Slysz GW, et al. A unique mode of microtubule stabilization induced by peloruside A. J Mol Biol 2008;378:1016–30
   PubMed Web of Science ®Google Scholar
• Khrapunovich-Baine M, Menon V, Yang C-PH, et al. Hallmarks of molecular action of microtubule stabilizing agents. J Biol Chem 2011;286:11765–78
   PubMed Web of Science ®Google Scholar
• Farce A, Loge C, Gallet S, et al. Docking study of ligands into the colchicine binding site of tubulin. J Enzyme Inhib Med Chem 2004;19:541–7
   PubMed Web of Science ®Google Scholar
• Liao SY, Chen JC, Miao TF, et al. Binding conformations and QSAR of CA-4 analogs as tubulin inhibitors. J Enzyme Inhib Med Chem 2010;25:421–9
   PubMed Web of Science ®Google Scholar
• Xu S, Chi S, Jin Y, et al. Molecular dynamics simulation and density functional theory studies on the active pocket for the binding of paclitaxel to tubulin. J Mol Model 2012;18:377–91
   PubMed Web of Science ®Google Scholar
• Varzhabetyan LR, Glazachev DV, Nazaryan KB. Molecular dynamics simulation study of tubulin dimer interaction with cytostatics. Mol Biol 2012;46:316–21
   Web of Science ®Google Scholar
• Discovery Studio 2.0. Accelrys Software Inc., San Diego, California, USA; 2007
   Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–91
   PubMed Web of Science ®Google Scholar
• Lu Y, Chen J, Xiao M, et al. An Overview of tubulin inhibitors that interact with the colchicine binding site. Pharm Res 2012;29:2943–71
   PubMed Web of Science ®Google Scholar
• Case DA, Cheatham TA, Simmerling CL, et al. AMBER 10, University of California, San Francisco, San Francisco, CA; 2008
   Google Scholar
• Becke AD. A new mixing of Hartree-Fock and local density functional theories. J Chem Phys 1993;98:1372–7
   Web of Science ®Google Scholar
• Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 09, Revision A.1. Gaussian Inc., Wallingford, CT; 2009
   Google Scholar
• Bayly CI, Cieplak P, Cornell WD, Kollman PA. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges – the RESP model. J Phys Chem 1993;97:10269–80
   Web of Science ®Google Scholar
• Wang J, Wolf RM, Caldwell JW, et al. Development and testing of a general amber force field. J Comput Chem 2004;25:1157–74
   PubMed Web of Science ®Google Scholar
• Jorgensen WL, Chandrasekhar J, Madura JD, et al. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983;79:926–35
   Web of Science ®Google Scholar
• Essman U, Perera L, Berkowitz ML, et al. A smooth particle mesh Ewald method. J Chem Phys 1995;103:8577–93
   Web of Science ®Google Scholar
• Andersen HC. Rattle: a “velocity” version of the shake algorithm for molecular dynamics calculations. J Comput Phys 1983;52:24–34
   Web of Science ®Google Scholar
• Fogolari F, Brigo A, Molinari H. Protocol for MM/PBSA molecular dynamics simulations of proteins. Biophys J 2003;85:159–66
   PubMed Web of Science ®Google Scholar
• HyperChem, release 6.03. Hypercube Inc., Waterloo, Canada; 2001
   Google Scholar